0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Anti-inflammatory Therapeutics Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-4J2573
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
China Anti inflammatory Therapeutics Market Report Forecast 2021 2027

China Anti-inflammatory Therapeutics Market Report & Forecast 2021-2027

Code: QYRE-Auto-4J2573
Report
October 2021
90 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
China Anti-inflammatory Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Anti-inflammatory Therapeutics Market Segment Percentages, By Type, 2020 (%)
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
China Anti-inflammatory Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Anti-inflammatory Therapeutics Market Segment Percentages, By Application, 2020 (%)
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-inflammatory Therapeutics revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Anti-inflammatory Therapeutics revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
1 Introduction to Research & Analysis Reports
1.1 Anti-inflammatory Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Anti-inflammatory Therapeutics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Anti-inflammatory Therapeutics Overall Market Size
2.1 China Anti-inflammatory Therapeutics Market Size: 2021 VS 2027
2.2 China Anti-inflammatory Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-inflammatory Therapeutics Players in China Market
3.2 Top China Anti-inflammatory Therapeutics Companies Ranked by Revenue
3.3 China Anti-inflammatory Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Anti-inflammatory Therapeutics Companies in China Market, by Revenue in 2020
3.5 Companies Anti-inflammatory Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-inflammatory Therapeutics Players in China Market
3.6.1 List of Tier 1 Anti-inflammatory Therapeutics Companies in China
3.6.2 List of Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Anti-inflammatory Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Anti-inflammatory Biologics
4.1.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
4.1.4 Corticosteroids
4.1.5 Others
4.2 By Type - China Anti-inflammatory Therapeutics Revenue & Forecasts
4.2.1 By Type - China Anti-inflammatory Therapeutics Revenue, 2016-2021
4.2.2 By Type - China Anti-inflammatory Therapeutics Revenue, 2022-2027
4.2.3 By Type - China Anti-inflammatory Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Anti-inflammatory Therapeutics Market Size, 2021 & 2027
5.1.2 Arthritis
5.1.3 Respiratory Diseases
5.1.4 Dermatology
5.1.5 Gastroenterology
5.1.6 Others
5.2 By Application - China Anti-inflammatory Therapeutics Revenue & Forecasts
5.2.1 By Application - China Anti-inflammatory Therapeutics Revenue, 2016-2021
5.2.2 By Application - China Anti-inflammatory Therapeutics Revenue, 2022-2027
5.2.3 By Application - China Anti-inflammatory Therapeutics Revenue Market Share, 2016-2027
6 Anti-inflammatory Therapeutics Companies Profiles
6.1 AbbVie
6.1.1 AbbVie Company Details
6.1.2 AbbVie Business Overview
6.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
6.1.4 AbbVie Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.1.5 AbbVie Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Details
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
6.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.2.5 Johnson & Johnson Recent Developments
6.3 Amgen Inc
6.3.1 Amgen Inc Company Details
6.3.2 Amgen Inc Business Overview
6.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
6.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.3.5 Amgen Inc Recent Developments
6.4 AstraZeneca PLC
6.4.1 AstraZeneca PLC Company Details
6.4.2 AstraZeneca PLC Business Overview
6.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
6.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.4.5 AstraZeneca PLC Recent Developments
6.5 Pfizer, Inc
6.5.1 Pfizer, Inc Company Details
6.5.2 Pfizer, Inc Business Overview
6.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
6.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.5.5 Pfizer, Inc Recent Developments
6.6 Novartis
6.6.1 Novartis Company Details
6.6.2 Novartis Business Overview
6.6.3 Novartis Anti-inflammatory Therapeutics Introduction
6.6.4 Novartis Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.6.5 Novartis Recent Developments
6.7 Roche
6.7.1 Roche Company Details
6.7.2 Roche Business Overview
6.7.3 Roche Anti-inflammatory Therapeutics Introduction
6.7.4 Roche Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.7.5 Roche Recent Developments
6.8 Merck
6.8.1 Merck Company Details
6.8.2 Merck Business Overview
6.8.3 Merck Anti-inflammatory Therapeutics Introduction
6.8.4 Merck Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.8.5 Merck Recent Developments
6.9 Sanofi
6.9.1 Sanofi Company Details
6.9.2 Sanofi Business Overview
6.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
6.9.4 Sanofi Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.9.5 Sanofi Recent Developments
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Company Details
6.10.2 GlaxoSmithKline Business Overview
6.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
6.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.10.5 GlaxoSmithKline Recent Developments
6.11 Sun Pharmaceutical Industries Ltd
6.11.1 Sun Pharmaceutical Industries Ltd Company Details
6.11.2 Sun Pharmaceutical Industries Ltd Business Overview
6.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
6.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.11.5 Sun Pharmaceutical Industries Ltd Recent Developments
6.12 TEVA
6.12.1 TEVA Company Details
6.12.2 TEVA Business Overview
6.12.3 TEVA Anti-inflammatory Therapeutics Introduction
6.12.4 TEVA Anti-inflammatory Therapeutics Revenue in China Market (2016-2021)
6.12.5 TEVA Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
    Table 1. Anti-inflammatory Therapeutics Market Opportunities & Trends in China Market
    Table 2. Anti-inflammatory Therapeutics Market Drivers in China Market
    Table 3. Anti-inflammatory Therapeutics Market Restraints in China Market
    Table 4. Key Players of Anti-inflammatory Therapeutics in China Market
    Table 5. Top Anti-inflammatory Therapeutics Players in China Market, Ranking by Revenue (2019)
    Table 6. China Anti-inflammatory Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. China Anti-inflammatory Therapeutics Revenue Share by Companies, 2016-2021
    Table 8. Companies Anti-inflammatory Therapeutics Product Type
    Table 9. List of Tier 1 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Anti-inflammatory Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – China Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2021 & 2027
    Table 12. By Type - China Anti-inflammatory Therapeutics Revenue (US$, Mn), 2016-2021
    Table 13. By Type - China Anti-inflammatory Therapeutics Revenue (US$, Mn), 2022-2027
    Table 14. By Application – China Anti-inflammatory Therapeutics Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Application - China Anti-inflammatory Therapeutics Revenue (US$, Mn), 2016-2021
    Table 16. By Application - China Anti-inflammatory Therapeutics Revenue (US$, Mn), 2022-2027
    Table 17. AbbVie Company Details
    Table 18. AbbVie Business Overview
    Table 19. AbbVie Anti-inflammatory Therapeutics Product
    Table 20. AbbVie Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 21. AbbVie Recent Developments
    Table 22. Johnson & Johnson Company Details
    Table 23. Johnson & Johnson Business Overview
    Table 24. Johnson & Johnson Anti-inflammatory Therapeutics Product
    Table 25. Johnson & Johnson Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 26. Johnson & Johnson Recent Developments
    Table 27. Amgen Inc Company Details
    Table 28. Amgen Inc Business Overview
    Table 29. Amgen Inc Anti-inflammatory Therapeutics Product
    Table 30. Amgen Inc Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 31. Amgen Inc Recent Developments
    Table 32. AstraZeneca PLC Company Details
    Table 33. AstraZeneca PLC Business Overview
    Table 34. AstraZeneca PLC Anti-inflammatory Therapeutics Product
    Table 35. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 36. AstraZeneca PLC Recent Developments
    Table 37. Pfizer, Inc Company Details
    Table 38. Pfizer, Inc Business Overview
    Table 39. Pfizer, Inc Anti-inflammatory Therapeutics Product
    Table 40. Pfizer, Inc Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 41. Pfizer, Inc Recent Developments
    Table 42. Novartis Company Details
    Table 43. Novartis Business Overview
    Table 44. Novartis Anti-inflammatory Therapeutics Product
    Table 45. Novartis Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 46. Novartis Recent Developments
    Table 47. Roche Company Details
    Table 48. Roche Business Overview
    Table 49. Roche Anti-inflammatory Therapeutics Product
    Table 50. Roche Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 51. Roche Recent Developments
    Table 52. Merck Company Details
    Table 53. Merck Business Overview
    Table 54. Merck Anti-inflammatory Therapeutics Product
    Table 55. Merck Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 56. Merck Recent Developments
    Table 57. Sanofi Company Details
    Table 58. Sanofi Business Overview
    Table 59. Sanofi Anti-inflammatory Therapeutics Product
    Table 60. Sanofi Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 61. Sanofi Recent Developments
    Table 62. GlaxoSmithKline Company Details
    Table 63. GlaxoSmithKline Business Overview
    Table 64. GlaxoSmithKline Anti-inflammatory Therapeutics Product
    Table 65. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 66. GlaxoSmithKline Recent Developments
    Table 67. Sun Pharmaceutical Industries Ltd Company Details
    Table 68. Sun Pharmaceutical Industries Ltd Business Overview
    Table 69. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
    Table 70. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 71. Sun Pharmaceutical Industries Ltd Recent Developments
    Table 72. TEVA Company Details
    Table 73. TEVA Business Overview
    Table 74. TEVA Anti-inflammatory Therapeutics Product
    Table 75. TEVA Anti-inflammatory Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
    Table 76. TEVA Recent Developments
List of Figures
    Figure 1. Anti-inflammatory Therapeutics Segment by Type
    Figure 2. Anti-inflammatory Therapeutics Segment by Application
    Figure 3. China Anti-inflammatory Therapeutics Market Overview: 2020
    Figure 4. China Anti-inflammatory Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
    Figure 5. China Anti-inflammatory Therapeutics Revenue, 2016-2027 (US$, Mn)
    Figure 6. The Top 3 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2020
    Figure 7. By Type - China Anti-inflammatory Therapeutics Revenue Market Share, 2016-2027
    Figure 8. By Application - China Anti-inflammatory Therapeutics Revenue Market Share, 2016-2027
    Figure 9. AbbVie Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 10. Johnson & Johnson Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 11. Amgen Inc Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 12. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 13. Pfizer, Inc Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 14. Novartis Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 15. Roche Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 16. Merck Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 17. Sanofi Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 18. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 19. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 20. TEVA Anti-inflammatory Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and China Membrane Bioreactor MBR Systems Market Insights Forecast to 2027
Global and China Membrane Bioreactor (MBR) Systems Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24N7565
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Oligonucleotide API Market Insights Forecast to 2027
Global and China Oligonucleotide API Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34J7553
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and Japan Prokaryotic Recombinant Protein Market Insights Forecast to 2027
Global and Japan Prokaryotic Recombinant Protein Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20U7714
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Lentiviral Vector In Gene Therapy Market Insights Forecast to 2027
Global and China Lentiviral Vector In Gene Therapy Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-30V7563
Tue Nov 30 00:00:00 UTC 2021

Add to Cart